XPO1 and neuroblastoma: Given its broad sensitivity across neuroblastoma cell lines, and its safety when used in children, selinexor is a unique agent that may introduce novel oncogenic vulnerabilities, in particular once there is an improved mechanistic understanding of the role of XPO1 in cancer development and aggressiveness.